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Abstract 
Glycerophospholipid: cholesterol acyltransferase (GCAT) is an enzyme produced by 
the bacteria Aeromonas salmonicida. A. salmonicida is the causative agents of the 
fish disease furunculosis and GCAT is an important enzyme when considering the 
virulence and progression of this disease. 
This study aims to show how the cytotoxic affects of the GCAT enzyme can vary 
between mammalian and fish cells. Both cloned and crude native forms of GCAT 
were exposed to mammalian and fish cell lines and observed for signs of damage 
over a 24 hour period. The cloned GCAT extraction was exposed to both fish and 
mammalian erythrocytes, while the crude native form was exposed to just 
mammalian erythrocytes to check for cytolytic activity. 
This study shows that GCAT produced from an A. salmonicida A-layer mutant is 
capable of lysing mammalian erythrocytes, as well as Chinese Hamster Ovary 
(CHOs) cell lines and lysis of Goldfish Skin (GFSK) cell lines.  However once a 
cloned, purer, sample of GCAT was produced by transformation of the GCAT gene 
into E. coli, the GCAT product was incapable of lysing CHO cell lines but retained its 
ability to lyse fish cells in the form of Rainbow Trout Gonad (RTG) cell lines. The 
purified GCAT also demonstrated low levels of haemolysis with both mammalian and 
fish erythrocytes.    
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1. Introduction 
Aeromonas salmonicida is a species of gram negative bacterium that contain five 
subspecies; ssp. salmonicida, ssp. achromogenes, ssp. masoucida, ssp. smithia and 
ssp. pectinolytica. None of these are considered to be any pathogenic threat to 
humans as they are incapable of growth at human body temperatures (Reith et al, 
2008). The main difference between the subspecies of A. salmonicida is the 
presence of different LPS and surface proteins on the bacterial A-Layer. This layer is 
thought to be very important to the virulence of A. salmonicida and has been shown 
to protect the bacteria from bactericidal activity in serum and provide protection 
against phagocytes (Lund et al, 2008).  
A. salmonicida spp salmonicida is responsible for the fish disease known as typical 
furunculosis. The other four subspecies are still capable of inducing furunculosis but 
it is referred to as atypical furunculosis (Magnadóttir et al, 2002). 
The disease presents with haemorrhagic areas around the pectoral fins and mouth, 
also ulcerative lesions on the dorsal and ventral surfaces (Santos et al., 2005). 
Furunculosis, both typical and atypical, was endemic in areas with intensively 
produced fish stocks, such as Iceland and Scotland. The disease caused huge loss 
of fish stock before mass vaccination programmes were introduced. 
GCAT itself has been known to be lethal to salmonid species of fish since as early as 
1981 (Titball & Munn 1981). The gene encoding for GCAT (specifically in Aeromonas 
salmonicida spp salmonicida) was sequenced in 1996 by Nerland. It consisted of 
1005bp which coded for a total of 335 amino acids, an 18 amino acid signal peptide 
(responsible for directing the post-translational modification of the polypeptide) and a 
317 amino acid mature polypeptide. The 317 amino acid mature polypeptide had a 
molecular mass of 38kDa. However, free non-dimerised GCAT has a molecular 
weight of 26kDa (Lee and Ellis, 1990), this implies that the 317aa GCAT is simply a 
proform and must require cleaving to become fully active. 
 
GCAT can exist in a number of forms in the natural environment. That is to say that 
GCAT can be a monomer, a dimer, a polypeptide aggregate or a single polypeptide 
complexed to LPS. In 2006, Eggset et al measured that around 10% of haemolytic 
activity of GCAT was due to a complexed form, 35-40% activity due to aggregated 
GCAT and the other 50% activity to free GCAT. 
 
GCAT also bears large similarities to a human enzyme known as lecithin-cholesterol 
acyltransferase (LCAT). There are a few differences between the enzymes, mainly 
over the variety of compounds that the enzymes can use as acyl donors and 
receptors. Another important difference is that the disulphide bridge in LCAT has 
been shown to be essential for enzymatic function, whereas in GCAT removal of the 
bridge appears only to reduce the enzymes ability to withstand adverse conditions, 
not on its ability to carry out the reaction (Qu et al, 1993). 
 
This study is being carried out to test whether or not it would be possible to use the 
GCAT enzyme as a treatment for cancer. Biological components from microbes have 
been used for a long time; most notable are antibiotics which have saved millions of 
lives since Penicillin had its medicinal properties recognised in the early 1930s. 
Other more recent developments include using Streptokinase from Strepococci in 
the treatments of blood clots in myocardial infarction and pulmonary embolism. More 
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importantly, GCAT would not be the first application of a microbial product to anti-
cancer treatments. Lots of chemotherapy drugs come from microbial sources, these 
include Doxorubicin from Streptomyces peucetius, and Bleomycin from 
Streptomyces verticillus.  
 
Currently there is a lot of work on a compound known as borrelidin (Figure 1). 
Borrelidin is a polykeytide of Streptomyces parvulus, it has anti-malarial (Otoguro et 
al, 2003), anti-viral and antibacterial activity (Lumb  et al, 1965 ). Importantly it is also 
a proven anti-angiogenesis compound (Wakabayashi et al, 1997). Angiogenesis has 
been shown to be vital to both continued tumour growth and eventual metastasis; 
further to this, solid tumours beyond 2mm3 have been shown to require angiogenesis 
for continued growth (Ferrara and Kerbel, 2005). Angiogenesis inhibition is already a 
target of some chemotherapy drugs such as paclitaxel, sunitinib and sorafenib and 
so angiogenesis is established as an effective cancer treatment.  
 
Rather than using borrelidin produced directly from S. parvulus, work is being done 
on total biochemical synthesis of the molecule. In 2006 a set of borrelidin analogues 
were created by Wilkinson et al, using pre-cursor directed biosynthesis. They 
discovered that to retain the anti-cancer properties of the compound a nitrile group at 
C12 was crucial.  In 2008 Krishna et al, published a method for creating the main 
framework of borrelidin (C3-C17) including the above mention nitrile group. 
 
 
Figure 1. This shows the chemical structure of the molecule borrelidin. Picture from 
www.microbialscreening.com 
 
The above example shows that microbes have been used for a very long time to 
augment human health, so the fact that GCAT is a microbial product is no barrier to it 
becoming a treatment for cancer. 
 
2. Materials and Method 
 
2.1 Obtaining concentrated crude GCAT sample 
Cultures of MT004 (an A-layer mutant, fully missing the A-layer) were grown on a 
TSA medium. It was evident that the organism growing was A. salmonicida by the 
trademark brown rings that occur when Aeromonas species are grown on a 
tryptophan rich medium. 
 
After 48hours incubation 70ml of TSB was inoculated with 4 colonies of A. 
salmonicida from the TSA plate. The flask culture was placed in a shaken water bath 
at 22oC and a 20ml sample taken from the flask after 72 hours, centrifuged to 
remove cells and the supernatant stored at -20oC until used.  
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To concentrate the sample, supernatants were placed in a membrane concentrator 
(Millipore Miniplus 9061, 15kda) until it had concentrated down 200 times. 
 
2.2 Obtaining concentrated cloned GCAT sample 
The gene for GCAT was transformed into a DH1 E. coli strain. The gene was carried 
on plasmid PACYC184, clone P9. 1.5ml of E. coli was centrifuged for two minutes at 
7000 rpm in a microcentrifuge. The supernatant was removed and the cells were 
resuspended in 200µL of ice cold CaCl2. This was left on ice for 20 minutes and then 
centrifuged again in the same fashion. The supernatant was again removed and the 
pellet was resuspended in 100µL of ice cold CaCl2. The resuspended cells were then 
transferred to another microcentrifuge tube containing 10µL of transforming plasmid. 
A plasmid containing genes for both GCAT and kanamycin resistance was used. 
This was mixed and left on ice for 10 minutes. After 10 minutes the microcentrifuge 
tube was removed from the ice for five minutes, and then placed back on ice for 2o 
minutes. To heat shock the cells into up taking the plasmid they were placed in a 
42oC water bath for exactly two minutes. Then 0.9ml of LB broth was added to the 
microcentrifuge tube and left in a 37oC water bath for one hour. 
 
Three LB plates containing kanamycin were streaked with 10µL, 50µL and 100µL of 
transformed E. coli. One plate was spread with 100µL of untransformed E. coli as a 
control. They were then left for 48 hours to grow. 
 
Unfortunately in this case, colonies grew on the control as well as the test plate so 
they could not be used. I was provided with two 5ml vials of pre-prepared cloned 
GCAT obtained by the same method. These were concentrated in a membrane 
concentrator by 5 times. 
 
2.3 Sub-culturing cell lines 
All the cells used were as monolayers set in a 24 well plate. For the Chinese 
Hamster Ovary (CHOs) cell lines each well was set to a concentration of between 8 
x 105 and 1 x 106 cells per well. The growth medium used was HAMs F-12 (Sigma-
Aldrich®) + 10% FBS (Fetal Bovine Serum). 
 
For the Rainbow Trout Gonad cell lines (RTGs), each well was set at a concentration 
of 1 x 106 cells per well. The growth medium used was MEM (Minimum Essential 
Media, from GIBCO®) + NEAA (Non-Essential Amino Acids) + 10% FBS. 
 
For the Goldfish Skin (GFSK) cell lines each well was set at a concentration of 3 x 
105 cells per well. The growth medium used was L-15 + L-Glu + L-amino acids + 
10% FBS. 
 
They were all incubated for a 24 hour period and allowed to become confluent and 
cover at least 80% of the well floor before being exposed to either cloned or crude 
GCAT preparations. 
 
2.4 Exposing cell lines to crude GCAT (GFSK, CHO) 
The old culture medium was removed and the cells were covered in 200µL of fresh 
medium. Three wells had 2µL of GCAT added; two more wells had no GCAT added 
but had 2µL of DPBS added as a control. 
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2.5 Exposing cell lines (RTG and CHO) to cloned GCAT and further controls 
As with the crude GCAT, the cells were prepared by removal of the old culture 
medium and addition of 200µL fresh medium to each well. For the CHO cells, one 
well was exposed to 50µL GCAT, one was exposed to 100µL GCAT, one well to 5µL 
and one well to 10µL of concentrated E. coli supernatant (100x concentrated) and 
the last well was exposed to 100µL unconcentrated LB broth (E. coli growth 
medium).  
 
The RTG cells were exposed to the same conditions but they also has two extra 
wells that were not exposed to GCAT and acted as controls. 
To ensure all preparations were free from bacterial contamination, they were all 
passed through a .22µM filter. 
 
2.6 Exposing crude GCAT to mammalian erythrocytes 
A dilution factor was set up so that the first well in a 96 well plate contained 1µL of 
crude GCAT in 50µL PBS. The dilution factor halved the concentration of GCAT in 
every successive well for 10 wells. To each well 2µL of whole horse blood was 
added. Two wells contained no GCAT, and had 2µL of PBS added to function as a 
control. 
 
2.7 Exposing cloned GCAT to mammalian and fish erythrocytes 
Three wells containing 45µL PBS and 5oµL cloned GCAT were set up. To each of 
these wells 5µL horse erythrocytes was added. Two wells containing only 95µL PBS 
were set up as a control. The exposure to fish erythrocytes was carried out by the 
same method, Tilapia erythrocytes were used. 50µL of GCAT solution was used as 
the solution was only five times concentrated. 
 
3.  Results 
 
3.1 Effect of crude native GCAT on horse erythrocytes 
Crude native GCAT lysed horse erythrocytes. Over the course of one hour the 
lowest concentration that was able to cause complete lysis of 2µL horse erythrocytes 
was 0.011µL GCAT in 50µL PBS. Wells with lower concentrations of GCAT did 
display evidence of lysis but it was not complete. This was evident by a very fine red 
ring at the bottom of the well. In the wells that did undergo complete lysis this red 
ring had disappeared and the PBS had turned a darker shade of pink than those with 
incomplete lysis. The erythrocytes in cloned PBS showed no signs of lysis. 
 
3.2 Effect of crude native GCAT on CHOs 
Exposure of CHOs to the crude GCAT preparation causes lysis and severe damage 
to cells (Plate 1.). This damage is self evident when compared to the control well 
(Plate 2). The cells are a lot smaller, have less well defined membranes, appear a lot 
more granulated and are less confluent to the bottom of the well. All these changes 
were observed over a period of 24 hours during which time the cells were incubated 
at 36oC. 
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Plate 1. CHO cells 24 hours after exposure to crude GCAT preparation 
These cells display a much lower density, implying large levels of cell death, they are much 
less well defined, are quite granulated and show little, if any sign of ongoing mitosis 
 
 
 
Plate 2. Control CHO cells after 24 hours 
Healthy control CHOs. Notice the density, well defined membranes and signs of ongoing 
mitosis marked out by the highly refractive cells. 
 
3.3 Effect of crude native GCAT on GFSK cells  
The effect on GFSK cell line was much the same as the effect on CHOs. The cells 
showed signs of severe stress, with a much lower cell density, poorly defined 
membranes and appearing more granulated. The GFSK control is shown in Plate 3; 
the GFSK 24 hours post GCAT exposure is shown in Plate 4. The wells were 
incubated at 20oC for the 24 hours between exposure and results. 
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Plate 3. Control GFSK cells after 24 hours 
Healthy GFSK cells. Large, well defined cells at an appropriate density. There is evidence of 
ongoing mitosis with the highly refractive cells. 
 
 
 
Plate 4. GFSK cells 24 hours after exposure to crude GCAT preparations 
Cells are very small and misshaped making them very difficult to see. There is a much lower 
density of cells present, again suggesting a high level of lysis. There is however more 
evidence of ongoing mitosis as there is a relatively large number of highly refractive cells 
 
3.4 Effect of cloned GCAT on horse and Tilapia erythrocytes 
Purified GCAT concentrate had a limited lysing effect on both horse and tilapia 
erythrocytes. After one hour of exposure complete lysis had still not occurred. Tilapia 
blood showed greater levels of lysis within one hour than the horse blood, but lysis 
was observed in both cases. The level of lysis was determined relatively by the 
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shade of pink that the PBS became. The results indicated that there was a low level 
of ongoing lysis. The lowest concentration of GCAT that was capable of producing 
any lysis within the time frame was not determined.  
 
 
3.5 Effect of cloned GCAT on CHO cells 
Exposure of CHO cells to the cloned GCAT preparation had no discernible effect 
(Plate 5) on the cells in comparison to control wells. CHO cells were also exposed to 
other controls in the form of 10µL 50 times concentrated E. coli supernatant (Plate 6) 
and 100µL unconcentrated LB broth (Plate 7). Both of these controls resulted in 
noticeable, severe damage of the CHOs  
 
 
 
 
Plate 5. CHOs 24 hours after exposure to 100µL of purified GCAT extract 
The cells all appear healthy. They are at a healthy density; cells are well formed and well 
defined with signs of ongoing mitosis. 
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Plate 6. CHOs 24 hours after exposure to 10µL of concentrated E. coli supernatant 
The cells all appear to have shrunk, are much less well defined but appear to be at a similar 
density to the control wells. This implies there has been no, or limited, lysis of the CHO cells. 
There is still some evidence of ongoing lysis although it is less widespread than in the 
control well. 
 
 
 
Plate 7. CHOs 24 hours after exposure to 100µL of unconcentrated LB broth 
As with the CHOs that were exposed to E. coli supernatant, the cells appear smaller and 
less defined. These cells however appear at a lower density than the controls implying that 
some lysis has occurred. There is no evidence of ongoing mitosis, the brighter cells in this 
plate are simply out of focus. 
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3.6 Effect of cloned GCAT on RTG cells 
Exposure of RTG cells to purified and filtered GCAT lead to severe damage to all the 
cells in comparison to the control cells (Plate 8). The cells were exposed to two 
different concentrations of GCAT, 50µL (Plate 9) and 100µL (Plate 10). The 
difference between the two concentrations is evident to see after 24 hours, the well 
containing 100µL of GCAT displays cells that are much less well defined, rounded 
and bunched up and show no signs of mitosis. The 50µL GCAT well still shows signs 
of extensive damage. 
The RTG cells, like the CHOs, were exposed to concentrated E. coli (Plate 11) and 
unconcentrated LB broth (Plate 12) as controls. Unlike the CHOs however the RTGs 
were much more resilient to these compounds and showed no signs of adverse 
reactions to their inductions. 
 
 
 
Plate 8. RTG control cells after 24 hours 
These control cells all appear healthy. They are at an appropriate density; cells are all well 
formed with distinct borders and signs of ongoing mitosis. 
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Plate 9. RTG cells 24 hours after exposure to 50µL of cloned, filtered GCAT 
The cells show signs of heavy damage to most cells, however there are still some healthy 
cells present. They are at a much lower density than the control cells and have less well 
defined and improperly formed membranes. There is also no sign of ongoing mitosis 
 
 
 
Plate 10. RTG cells 24 hours after exposure to 100µL of cloned, filtered GCAT 
The cell shows signs of extensive damage to every cell in the culture. They are all shrunken, 
rounded and granular. They are at a lower density than the control wells, but at a higher 
density than the 50µL GCAT plate but have no viable cells. 
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Plate 11. RTG cells 24 hours after exposure to 10µL concentrated E. coli supernatant 
These cells, in contrast to CHOs, appear healthy. They are at an appropriate density; cells 
are all well formed with distinct borders and signs of ongoing mitosis 
 
 
 
Plate 12. RTG cells 24 hours after exposure to 100µL of unconcentrated LB broth 
These cells all appear healthy, all cells are similar in appearance to both the control and the 
E. coli wells. 
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4. Discussion 
 
4.1 Effect of crude GCAT on GFSK and CHO cells 
The crude GCAT preparation effectively lysed GFSK and CHO cells, as well as 
horse erythrocytes. When the genome of A. salmonicida was sequenced in 2008, by 
Reith et al they found genes for 15 different secreted enzymes (including one 
pseudogene, rendered inert by a frame shift mutation). These secreted enzymes 
include three other proteases, a serene protease and two different metalloproteases. 
Two different amylases, two different extracellular nucleases and a further two 
phospholipases were found. Any of these enzymes could explain why the crude 
GCAT preparation was able to lyse mammalian cells as well as fish cells. 
 
As well as the secretable enzymes described above, A. salmonicida is capable of 
producing and secreting three different toxins (two more have been rendered 
pseudogenes by frame shift and an insertion mutation). These toxins are Aerolysin, 
Haemolysin and RTX-Cytotoxin. Aerolysin is known to have an effect on mammalian 
cells (Abrami et al, 1998, Nelson et al, 2002). Haemolysin will have an effect on 
erythrocytes and explains the lysis of whole horse blood. RTX-Cytotoxin is also 
known to have a toxic effect on mammalian cells. Broadly they fall into two 
categories, haemolysins and leukotoxins, both of which are capable off interacting 
with, and harming mammalian cells (Lally et al, 1997, Lally et al, 1999).   
  
Further work would have to be done to discover which of these, if any, had the 
greatest cytolytic effect on the mammalian cells. The lysing effect of the fish cells 
could also have been performed by any of the above enzymes, but the GCAT 
enzyme has been established as the major lethal toxin in A. salmonicida since 1981 
(Titball and Munn, 1981), so it is reasonable to assume that this is the major 
influence in the cell death. 
 
4.2 Effect of cloned CGAT on RTG and CHO cells 
The cloned GCAT was able to lyse the RTG fish cells but was unable to lyse, or at all 
affect, the CHO mammalian cells. This was the expected result for both cell types. 
As purified GCAT was not used, it cannot be said conclusively that it was the CGAT 
that lysed the RTG cells, however as was stated in 4.1 it has long been known that 
GCAT is the major lethal toxin involved. All that can be definitively concluded is that 
whatever was responsible for the lysing of the fish cells is unable to lyse the 
mammalian cells under the same conditions. 
 
4.3 Effect of concentrated E. coli supernatant and unconcentrated LB broth on 
RTG and CHO cells 
The CHO cells were lysed upon exposure to both concentrated E.coli supernatant 
and normal LB broth. The RTG cells were not harmed by either of the two 
preparations. 
 
The fact that the CHOs were unharmed by the cloned GCAT preparations, while 
suffering severe damage when combined with concentrated E. coli supernatant 
suggests an anomalous result. This is because the only difference between the two 
preparations should have been the presence or absence of GCAT. 
 
The one difference between the two preparations (excluding the presence or 
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absence of GCAT) was the amount of times the preparations were concentrated. 
Both the E. coli supernatant with GCAT and E. coli supernatant without GCAT were 
left overnight in a membrane concentrator; however they only concentrated down 
five times and 50 times respectively. From this, one can hypothesise that there will 
be a compound (compound X) in E. coli supernatant which has cytotoxic properties 
to CHO cells and is too large to be filtered out by the membrane concentrator 
(therefore, >15kDa). X was not at a high enough concentration in the 5 times 
concentrated, GCAT positive preparation and so could not have an appreciable 
effect on the CHO cells within 24 hours.  When X was 50 times concentrated it was 
at a high enough concentration to have a visible effect within 24 hours. 
 
The problem with this hypothesis is that only 10µL of the 50 times concentrated, 
GCAT negative E. coli supernatant was added, as opposed to 100µL of the five 
times concentrate. This means that in theory the same amount of X was added to 
each well. However in the GCAT negative E. coli supernatant, that lysed the CHO 
cells, the total volume of the well would have been 210µL, compared to 300µL in the 
GCAT positive well, so X would have been at a higher overall concentration.  
 
Whether or not so named, X, was responsible would need further experimentation. 
The RTG cells were not lysed by just E. coli supernatant, but they were lysed by the 
cloned GCAT preparation. The RTG cells were also unaffected by addition of 
unconcentrated LB broth, while the CHO cells were heavily damaged by the addition 
of LB broth. This implies the presence of an endotoxin (most likely an LPS or a 
derivative of) that is removed by the membrane concentrator. This endotoxin would 
have an action against CHO cells but either have no, or reduced, effect on the RTG 
cells.  
 
 
4.4 Conclusion and Validity of Results 
The conclusions for the study are that concentrated A. salmonicida supernatant is 
capable of lysing mammalian cells and fish cells alike. Also E. coli with the 
transformed GCAT gene is capable of only lysing fish cells, and has no discernible 
effect on mammalian cells after a 24 hour period. 
 
The aim of this study was to assess the feasibility of applying the GCAT enzyme as 
an anti-cancer treatment. For GCAT to be able to successfully differentiate between 
mammalian and fish cells, there must be a cellular marker, or cellular makeup, that 
GCAT recognises that is not present in mammalian cells but is present in fish cells (it 
is assumed to be present in fish cells as A. salmonicida is a fish pathogen and so its 
extracellular products must be able to positively identify fish cells). 
 
The difference that is recognised by GCAT could be the percentage of fatty acids in 
the cell membrane. Mammalian cell membranes have around a 30% fatty acid make 
up, while fish cells typically are made up of 60% fatty acids (Gilpin, 2009, personal 
communication). If this is the cellular property recognised by GCAT then, in theory, a 
neoplastic cell that acquires a mutation that leads to an increase in the fatty acid 
content of the cell membrane, it could be selectively targeted and destroyed by the 
GCAT, along with all the progeny of the aforementioned cell. 
 
It is already known that modification of the cell membrane content can increase the 
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susceptibility of cells to autolysis. In 1980, Yoo et al, found that an increase in fatty 
acid membrane composition in hepatoma cells led to increased rates of complement 
mediated cytolysis. The increase in lysis due to a change in osmotic potential of the 
cell was ruled out by a control. They also found that the degree to which 
susceptibility increases is relative to the change in lipid content of the cell 
membrane. In 1982 another paper by Yoo et al, demonstrated that an increase in 
fatty acid composition of hepatoma cells makes them more susceptible to the action 
of natural killer cells. They found that specific lysis of the fat enriched cells increased 
by 60% relative to the control (P= <0.01). Both of these papers by Yoo et al used rat 
hepatoma cells, which are a mammalian cell line so the results may carry over to 
other mammals. Both experiments were also carried out in vitro so it cannot be 
applied to normal biology as a certainty. 
 
In 1987 Burns and Spector, carrier out an in vivo experiment on the affect of altering 
membrane content of L1210 leukaemia cells in carrying mice. They found that the 
increase in membrane fatty acid content was accompanied by an increase in 
susceptibility to Adriamycin and hyperthermia treatments. These experiments show 
that an increase in the fatty acid content of cell membranes can be used as a target 
for therapeutic intervention. However none of the papers show that the cancer cells 
could achieve this increase in fatty acid content without either being grown in a fat 
rich environment or having the host fed on a fat rich diet. 
 
There are however a few papers that show the importance of the enzyme fatty acid 
synthase to the survival and proliferation of a range of cancers (Pizer et al, 1996, 
Pizer et al, 1996, Kuhajda, 2002, to name just three). Although it is not stated in the 
papers, it could be speculated that if a cancer cell were to acquire a mutation that 
increased the efficiency of fatty acid synthase then that cell would inherit a significant 
proliferative advantage and could be preferentially targeted by the GCAT enzyme 
based upon the associated increase in the fatty acid composition of the cell 
membrane. 
 
 
4.5 Targets for further work 
As only cloned GCAT was used, I would like to repeat the experiment using purified 
GCAT enzyme. A method for producing purified GCAT using fast protein liquid ion-
exchange chromatography was outlined by Lee and Ellis, 1990. This would remove 
the possibility of any interference from extracellular products of E. coli. Further to this 
work I would like to test a greater range of mammalian cells to test that the lack of 
degradation of CHO cells is not due to a special resistance property of CHO cells. 
If all mammalian cell lines proved to be immune to GCAT then I would attempt to 
subculture a mix of human and fish cell lines together, then expose them to purified 
GCAT and observe if GCAT would preferentially break down the fish cells. 
If this proved successful then I would attempt to find a cancer cell line with raised 
phospholipid content, with which GCAT could react. Once this cell line was found, 
and it was established that GCAT could lyse the mutated mammalian cells, a 
subculture of healthy and mutated (with the raised phospholipid content) would be 
raised and exposed to GCAT to see if GCAT could preferentially lyse the mutated 
cells while not acting upon the healthy cells. 
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